Figure 1
Flow chart for categorizing antithrombotic guideline adherence, amongst patients with follow-up. *In high-risk patients without CAD and diabetes. AP, antiplatelet agent. All patients with follow-up: pink = over-treatment (n = 574); light green = guideline adherent (n = 1602); grey = undertreatment (n = 458). For high-risk patients only: pink = over-treatment (n = 514); light green = guideline adherent (n = 1513); grey = undertreatment (n = 433). Amongst ‘low risk’ if scheduled for cardioversion, these are re-categorized as high risk. Also, any patients with recent ACS or stents would be re-categorized as ‘high risk’ and ‘guideline adherent’ (light green).

Flow chart for categorizing antithrombotic guideline adherence, amongst patients with follow-up. *In high-risk patients without CAD and diabetes. AP, antiplatelet agent. All patients with follow-up: pink = over-treatment (n = 574); light green = guideline adherent (n = 1602); grey = undertreatment (n = 458). For high-risk patients only: pink = over-treatment (n = 514); light green = guideline adherent (n = 1513); grey = undertreatment (n = 433). Amongst ‘low risk’ if scheduled for cardioversion, these are re-categorized as high risk. Also, any patients with recent ACS or stents would be re-categorized as ‘high risk’ and ‘guideline adherent’ (light green).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close